-
The economic impact of the Indian diaspora - October 1, 2024
-
JOKE OF THE DAY : What do you call a lazy kangaroo? - October 1, 2024
-
Vegetable Fried Rice Recipe - October 1, 2024
-
LONDON: Indian-Origin Teen In UK Gets “Life-Changing” Cancer Treatment - October 1, 2024
-
JOKE OF THE DAY : I was going to tell a time traveling joke. - August 12, 2024
-
Methi Matar Malai Recipe - August 4, 2024
-
Indian diaspora and economic development of India - August 1, 2024
-
NEW DELHI: Youngsters’ Increasing Stress Levels, Early Onset of Diseases an Alarming Health Trend: Apollo Hospitals Chief - July 28, 2024
-
Rava Idli | Suji ki Idli - May 28, 2024
-
IRELAND: “From 800 to 7,000”: Ireland’s Education Appeal Soars Among Indian Students - May 4, 2024
LUSAKA : India offers support for Africa to fight the Omicron variant
LUSAKA : We have noted the emergence of a new variant of Covid-19, Omicron. We express our solidarity with the countries, particularly in Africa, who have so far been affected by the Omicron variant.
The Government of India stands ready to support the countries affected in Africa in dealing with the Omicron variant, including by supplies of Made-in-India vaccines. Supplies can be undertaken through COVAX or bilaterally.
In this regard, the Government has cleared all orders placed so far by COVAX for supplies of COVISHIELD vaccines including to African countries like Malawi, Ethiopia, Zambia, Mozambique, Guinea and Lesotho. We have also cleared supplies of COVAXIN to Botswana.
Any new requirement projected either bilaterally or through COVAX will be considered expeditiously. India also stands ready to supply essential life-saving drugs, test kits, gloves, PPE kits and medical equipment such as ventilators, as may be required.
Indian institutions would favourably consider cooperation in genomic surveillance and virus characterization related research work with their African counterparts. India has, so far, supplied more than 25 million doses of Made-in-India vaccines to 41 countries in Africa, including nearly 1 million doses as grant to 16 countries and more than 16 million doses under the COVAX facility to 33 countries.]